Researchers have made a smart contact lens that could be used to monitor diabetes and dispense drugs on-demand. The system includes cool-looking eyeglasses that wirelessly power and communicate with the circuit-lined, drug-releasing lens that a patient could wear for up to a month.
Continue reading… “Smart contact lens monitors diabetes and delivers drugs”
EHang recently announced an agreement to deploy a fleet of passenger drones for the purpose of delivering organs to transplant patients. The Manufactured Organ Transport Helicopter (MOTH) will work with Maryland-based Lung Biotechnology PBC to customize the 184-drone to well suited for the task.
An institutional Review Board has given ethical permission to stimulate the brains of 20 brain dead patients to see if people can be partly revived. The highly controversial study, ReAnimaproject, which will start next year in India, will stimulate the nervous system in order to restore the brain.
High drug prices are restricting people who need access to potentially life saving medications, from getting what they need. In the U.S. when government authorized patents expire, pharmaceutical companies rush to buy the patents and raise the prices of drugs by 6,000 percent. Martin Shkreli, at a conference, said he didn’t go far enough when raising the price of HIV drug Daraprim by more than 5,000 percent. Now with the rapid growth of digital and medical technology some may have to rethink their strategies for the future.
29 patients with advanced type leukemia that were resistant to multiple other forms of therapy had their genes genetically engineered. Of those 29 patients 27 of them went into remission after receiving the treatment making this new immunotherapy a strong candidate for curing cancer.
Continue reading… “New immunotherapy leaves 93 percent of advanced leukemia patients in remission”
Elizabeth Parrish, CEO of Bioviva USA Inc, has undergone a gene therapy, created by her own company that has reversed 20 years of telomere shortening. This makes Parrish the first human to be successfully rejuvenated by gene therapy. Telomere score is calculated according to telomere length of white blood cells (T-lymphocytes). This result is based on the average T-lymphocyte telomere length compared to the American population at the same age range. The higher the telomere score, the “younger” the cells.
Continue reading… “Gene therapy against human aging successful”
Last month, a Toronto startup, Figure 1, reached a million users, double the amount it had seven months ago. Now more than a million health-care professionals use the platform, that is similar to Instagram, to share images of patient ailments, without identifiable information, to other doctors from around the world, to seek opinions and get help for their patients.
Johnson & Johnson is ramping up its latest project to learn how to predict who will develop particular diseases and also find therapies to prevent or stop the disease early on. Early prevention is the key.
Continue reading… “J&J project aims to predict and prevent diseases”
Over the next few weeks, while browsing on the dating app, Tinder, you may find an image of someone with an ‘organ donor’ icon next to their photo. By swiping right, you will be given the option to register as an organ donor.
Continue reading… “Due to three bioprinting breakthroughs, printable organs are here”
Scientists in France were able to restore the youth of cells taken from people 100 years of age and older. They reprogrammed them to stem cells stage, demonstrating that aging is in fact reversible.
Continue reading… “French researchers restore the youth of cells taken from 100 year old people”
Singularity University held its Exponential Medicine Conference last week in San Diego, a look at how technologists are redesigning and rebuilding today’s broken healthcare system.
Continue reading… “Why the $3 trillion healthcare system is broken and how we are going to fix it”
Editas CEO Katrine Bosley
Editas Medicine, a biotechnology startup, will begin tests of a powerful new form of gene repair in humans within two years. Speaking this week at the EmTech conference in Cambridge, Massachusetts, Editas CEO Katrine Bosley said the company hopes to start a clinical trial in 2017 to treat a rare form of blindness using CRISPR, a groundbreaking gene-editing technology.
Continue reading… “Biotechnology startup will begin testing CRISPR gene editing on humans in 2017”
By delving into the futuring techniques of Futurist Thomas Frey, you’ll embark on an enlightening journey.
Learn More about this exciting program.